Patients received ixabepilone ( @ mg/m ( @ ) as a @-hour intravenous infusion every @ weeks ) plus oral capecitabine ( @ mg/m ( @ ) administered twice each day ) , or capecitabine alone ( @ mg/m ( @ ) twice each day ) .